From 2016-20, drugmakers raised the prices of brand name drugs by 36 percent, nearly four times the rate of inflation during that period, according to a report detailing the findings of an investigation by the U.S. House Committee on Oversight and Reform.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,